Asset type Domestic Equity Sector
KODEX Biotech ETF invests in stocks of FnGuide Bio Index composed of both KOSPI and KOSDAQ stocks related to biotech industry.
Last data obtained Quotes delayed at least 20 minutes. Market data provided by KOSCOM.
Refers to the current value of future income generated from investments into bonds discounted at an appropriate discount rate.
Net Asset Value (NAV): Net Asset Amount refers to the assets of the ETF less the liabilities the ETF has to pay. This total Net Asset Amount divided by the total number of securities in the ETF is called the Base Price or Net Asset Value (NAV). In other words, NAV refers to the ETF per share value. It is announced once a day based on the closing market prices from the previous day.
Indicative NAV (iNAV): Value of the ETF calculated in real-time, reflecting the current price of the assets the ETF holds. Investors make their trades with reference to this price. As such, ETF transaction prices usually form approximate to the iNAV. Depending on the sentiment of market participants, however, the transaction price may be higher than the iNAV (overvaluation), or conversely lower than iNAV (undervaluation).
down 234 (-1.56%)
Trading Volume (shares)
* as of Feb 26, 2021
FnGuide Bio Index
The FnGuide Bio Index is designed to capture the performance of stocks related to the Biotech industry. Constituents are chosen among MKF2000 Medical Industry stocks, and must satisfy market capitalization and liquidity standards.View index information in detail
|Net Assets||24 (billion)||Base Currency||KRW|
|Inception Date||May 13, 2016||General
(AP : 0.020%, Manager fee : 0.390%, Trustee Fee : 0.020%, General Administrator Fee : 0.020%)
Quarterly and the last Business Day of fiscal year dividend distribution, only if applicable.
(Record date : last Business Day of January, April, July, and October, and fiscal year)
Samsung Asset Managementcompliance review No.2018-189 (2018.05.21)